IP Library Patent Application 13592300
Patent Application
App. No. 13/592,300

METHOD AND APPARATUS FOR SELF-DOSING AND SELF-ADMINISTERING PHARMACEUTICAL COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/592,300
Abstract

A method for self-dosing and self-administering a pharmaceutical or a cosmetic composition is provided. The method utilizes a three-dimensional dispensing device configured for receiving the composition. The dispensing device includes a bottom element having an inner surface and an outer surface and two side elements integrated with the bottom element, each side element being set at an angle to the bottom element.

Claims (34)

1 . A method for self-dosing and self-administering a formulation comprising a pharmaceutical or a cosmetic composition, the method comprising:

(a) providing a three-dimensional dispensing device configured for receiving the formulation, the dispensing device comprising:

(1) a bottom element having an inner surface and an outer surface;

(2) two side elements integrated with the bottom element, each side element being set at an angle to the bottom element, each side element having an inner surface and an outer surface; and

(3) optionally two lip elements, each lip element being integrated with each of the two side elements,

wherein the bottom element and the two side elements define an inner space contained therebetween, with the further provisos that:

the bottom element together with the two side elements comprise a central area for receiving the formulation,

the dispensing device is capable of being flattened by pressuring the bottom element, the two side elements and optionally the lip element into a two-dimensional shape;

(b) dispensing the required amount of the formulation onto the central area of the dispensing device;

(c) unfolding the dispensing device into the two-dimensional shape; and

(d) transferring the formulation from the dispensing device to the area of the user's body that is in need of treatment,

to self-dose and self-administer the formulation thereby.

2 . The method of claim 1 , wherein the formulation is selected from the group consisting of pharmaceutically acceptable or cosmetically useful creams, pastes, ointments, jellies and gels.

3 . The method of claim 1 , wherein the formulation comprises a pharmaceutically effective quantity of a pharmacologically active substance.

4 . The method of claim 3 , wherein the pharmacologically active substance is selected from the group consisting of ketoprofen, cyclopenzaprine, gabapentin, diclofenac, nitroglycerol, clonidine, prochlorperazine, scopolamine and hormones such as testosterone or secretin.

5 . The method of claim 2 , wherein the formulation has the viscosity of at least about 2,000 centipoise.

6 . The method of claim 5 , wherein the formulation has the viscosity between about 5,000 centipoise and about 500,000 centipoise.

7 . The method of claim 1 , wherein the dispensing device is fabricated of a flexible inert material.

8 . The method of claim 7 , wherein the flexible inert material is pharmaceutically or cosmetically acceptable and is selected from the group consisting of paper, plastic and a metal foil.

9 . The method of claim 1 , wherein the thickness of the dispensing device is less than about 2 mm.

10 . The method of claim 1 , wherein the length of the dispensing device is between about 70 mm and about 100 mm.

11 . The method of claim 1 , wherein the width of the dispensing device is between about 1 mm and about 50 mm.

12 . The method of claim 1 , wherein the height of the dispensing device is between about 5 mm and about 35 mm.

13 . The method of claim 1 , wherein the width of the central area of the dispensing device is between about 5 mm and about 100 mm.

14 . The method of claim 1 , wherein the amount of the composition dispensed onto the central area of the dispensing device is between about 100 mg and about 5 g.

15 . The method of claim 1 , wherein the inner space of the dispensing device conforms to a shape selected from the group consisting of a rectangular prism, a rectangular parallelepiped, a cuboid, a semi-cylinder, a truncated cone, a truncated prism and a truncated pyramid.

16 . The method of claim 1 , wherein each of the two side elements comprise at least one notch so that the width of the inner space is not uniform along the inner space's height dimension.

17 . The method of claim 1 , wherein the outer surface of at least one of the bottom element and two side elements includes instructions printed thereupon in a minor image manner.

18 . A kit for self-dosing and self-administering a formulation comprising a pharmaceutical or a cosmetic composition, the kit comprising:

(a) the three-dimensional dispensing device of claim 1 ; and

(b) a container containing the formulation,

wherein the dispensing device further includes instructions for use imprinted thereupon.

19 . The kit of claim 18 , wherein the dispensing device is disposable.

20 . The kit of claim 18 , wherein the dispensing device is reusable.

Assignments (3)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY COLLATERAL AT REEL/FRAME NO. 35923/0749 Recorded Jul 19, 2017
From: IMMY FUNDING LLC
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 043259/0434 →
SECURITY INTEREST Recorded Jun 16, 2015
From: IMPRIMIS PHARMACEUTICALS, INC.
To: IMMY FUNDING LLC
Reel/Frame 035923/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2012
From: BAUM, MARK L.; SCHUPP, JOACHIM P.H.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 028999/0981 →